Adicet Bio, Inc.’s $137.5 Million Rights Offering

Goodwin Procter LLP advised Adicet Bio, Inc. on the deal.Adicet Bio, Inc. (Nasdaq: ACET) announced its underwritten public offering of 10,575,513 shares of its common stock, including…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now